{
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "document": "Liu_et_al.__2024_",
  "additional_evidence_check": {
    "checked_for_more": true,
    "found_additional": true,
    "additional_count": 3
  },
  "completeness_stats": {
    "existing_evidence": 4,
    "new_evidence_found": 3,
    "total_evidence": 6
  },
  "combined_evidence": [
    {
      "id": 1,
      "quote": "The manufacturing process can lead to egg adapted mutations in the hemagglutinin (HA) protein in IIV, that could result in altered antigenicity and reduced vaccine effectiveness (VE) in the population.",
      "relevance_explanation": "This quote directly states that the manufacturing process for egg-based vaccines can cause mutations in the HA protein, which may change the antigenic properties of the vaccine and reduce its effectiveness, supporting the claim."
    },
    {
      "id": 2,
      "quote": "Repeat vaccination with egg based influenza vaccines could preferentially boost antibodies targeting the egg adapted epitopes and reduce immunogenicity to circulating viruses.",
      "relevance_explanation": "This quote explains that repeated use of egg-based vaccines can enhance immune responses to egg-adapted (mutated) epitopes rather than those found on circulating viruses, potentially reducing the vaccine's effectiveness."
    },
    {
      "id": 3,
      "quote": "Egg adaptation can introduce mutations in the HA protein that are not present in circulating viruses, potentially leading to a mismatch between vaccine-induced immunity and the actual circulating strains.",
      "relevance_explanation": "This statement highlights that mutations arising during egg-based vaccine production can cause a mismatch between the vaccine and circulating viruses, which may lower vaccine effectiveness."
    },
    {
      "id": 4,
      "quote": "Several studies have reported that Q223R egg adapted change at the HA head domain of A (H1N1) pdm09 virus can promote virus replication in eggs, alter antigenicity and influence immune response.",
      "relevance_explanation": "This quote provides a specific example of a mutation (Q223R) that occurs during egg-based production, which alters the antigenic properties of the virus and can affect the immune response, supporting the claim."
    },
    {
      "id": "comp_1",
      "quote": "Egg adaptation can introduce amino acid changes in the HA protein that are not present in the circulating viruses, potentially leading to a mismatch between vaccine-induced immunity and the actual circulating strains.",
      "relevance_explanation": "This quote directly states that egg adaptation during vaccine production can cause mutations in the HA protein, which may result in reduced effectiveness due to a mismatch with circulating viruses.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    },
    {
      "id": "comp_2",
      "quote": "Several studies have reported that Q223R egg adapted change at the HA head domain of A (H1N1) pdm09 virus can promote virus replication in eggs, alter antigenicity and influence immune response 37 42.",
      "relevance_explanation": "This quote provides evidence from multiple studies that specific mutations (such as Q223R) can arise during egg-based vaccine production, affecting antigenicity and immune response, which supports the claim about mutation-induced reduced effectiveness.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    }
  ],
  "completeness_assessment": {
    "missing_aspects": []
  },
  "model_used": "gpt-4.1"
}